Merck Handed First Loss in Fosamax Bellweather Trials
- Sunday, 10 February 2013
- News Roundup
A jury in New York City federal court has ruled that pharmaceutical giant Merck didn’t properly warn users about the risks associated with its osteoporosis drug Fosamax, according to a recent article from Reuters.
Read more...Most Read
- 
      
      
      
      
            
				- 
				Feb 08 2014
- 
		  
						Written by Administrator
 
- 
				
- 
      
      
      
      
            
				- 
				Apr 07 2013
- 
		  
						Written by PLP News
 
- 
				
- 
      
      
      
      
            
				- 
				Mar 20 2016
- 
		  
						Written by Administrator
 
- 
				
- 
      
      
      
      
            
				- 
				Apr 13 2016
- 
		  
						Written by Administrator
 
- 
				
 
			 
    	
	       
    	
	       
    	
	       
    	
	       
    	
	       
    	
	      